Search Results

Deals

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC.

November 27, 2023

·

4 min read

Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

Zealand Pharma A/S announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.

January 10, 2024

·

1 min read

Biotech Beach

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

MDxHealth SA announced its financial results for the first quarter ended March 31, 2024 and the closing of a new debt facility with OrbiMed.

May 1, 2024

·

12 min read

Press Releases

Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings

January 15, 2025

·

2 min read

Press Releases

Cycle Pharma Acquires Banner Life Sciences, LLC

January 13, 2025

·

17 min read

Press Releases

Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million

September 30, 2024

·

15 min read

Business

ChoiceSpine LLC Announces Changes in Leadership Roles

ChoiceSpine LLC, a medical device company in Knoxville, Tennessee, and privately held by Altus Capital Partners, announces that Marty Altshuler and Rick Henson, founders and Co-Presidents of ChoiceSpine, transitioned to Executive Advisor roles following 18 years of leading the company.

January 18, 2024

·

3 min read

Press Releases

WorldQuant Foundry Appoints Dr. Christopher Mason as Senior Healthcare Advisor to Spearhead AI-Driven Healthcare Innovation

January 17, 2025

·

2 min read

Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions

Spexis AG, a clinical-stage biopharmaceutical company focused on rare diseases and oncology, announced that it has engaged Maxim Group LLC as a financial advisor to assist in the evaluation of strategic alternatives and fundraising opportunities.

June 30, 2023

·

2 min read

Press Releases

Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach

January 14, 2025

·

4 min read